Efficacy of MEDI0618, a pH-dependent monoclonal antibody targeting PAR2, in preclinical models of migraine.
MEDI0618 是一种 pH 依赖性单克隆抗体，靶向 PAR2，在偏头痛的临床前模型中疗效
期刊:Brain
影响因子:11.7
doi:10.1093/brain/awae344
Kopruszinski Caroline M, Linley John E, Thornton Peter, Walker Alison S, Newton Philip, Podichetty Sadhana, Ruparel Radhey Hemendra, Moreira de Souza Luiz Henrique, Navratilova Edita, Meno-Tetang Guy, Gurrell Ian, Dodick David W, Dobson Claire, Chessell Tharani, Porreca Frank, Chessell Iain
